ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 52 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $303,000 | +4.8% | 280,000 | 0.0% | 0.00% | – |
| Q3 2020 | $289,000 | -6.5% | 280,000 | 0.0% | 0.00% | – |
| Q2 2020 | $309,000 | -14.2% | 280,000 | -21.1% | 0.00% | – |
| Q1 2020 | $360,000 | -55.9% | 355,000 | -50.3% | 0.00% | – |
| Q4 2019 | $817,000 | +0.1% | 715,000 | 0.0% | 0.00% | – |
| Q3 2019 | $816,000 | -3.4% | 715,000 | 0.0% | 0.00% | – |
| Q2 2019 | $845,000 | +1.6% | 715,000 | +16.3% | 0.00% | – |
| Q1 2019 | $832,000 | -56.9% | 615,000 | -65.9% | 0.00% | – |
| Q4 2018 | $1,931,000 | +1.8% | 1,805,000 | 0.0% | 0.00% | – |
| Q3 2018 | $1,896,000 | -5.2% | 1,805,000 | -11.3% | 0.00% | – |
| Q2 2018 | $1,999,000 | -0.5% | 2,035,000 | 0.0% | 0.00% | – |
| Q1 2018 | $2,010,000 | -6.5% | 2,035,000 | 0.0% | 0.00% | – |
| Q4 2017 | $2,149,000 | +14.6% | 2,035,000 | +14.6% | 0.00% | – |
| Q3 2017 | $1,875,000 | +23.2% | 1,775,000 | +23.7% | 0.00% | – |
| Q2 2017 | $1,522,000 | +57.9% | 1,435,000 | +43.5% | 0.00% | – |
| Q1 2017 | $964,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,821,000 | $11,314,000 | 1.07% |
| TFG Asset Management GP Ltd | 6,000,000 | $6,883,000 | 1.02% |
| Alken Asset Management Ltd | 400,000 | $461,000 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 6,525,000 | $7,470,000 | 0.54% |
| CSS LLC/IL | 8,000,000 | $9,158,000 | 0.51% |
| IRON Financial LLC | 505,000 | $578,000 | 0.28% |
| MACKAY SHIELDS LLC | 32,796,000 | $37,597,000 | 0.26% |
| OSTRUM ASSET MANAGEMENT | 400 | $459,000 | 0.22% |
| RWC Asset Management LLP | 4,400,000 | $5,037,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $5,580,000 | 0.16% |